MODV Stock Overview
A technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
ModivCare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.13 |
| 52 Week High | US$52.33 |
| 52 Week Low | US$10.63 |
| Beta | 0.54 |
| 1 Month Change | -31.76% |
| 3 Month Change | -6.55% |
| 1 Year Change | -74.64% |
| 3 Year Change | -92.68% |
| 5 Year Change | -81.21% |
| Change since IPO | -20.50% |
Recent News & Updates
Recent updates
ModivCare: A Complicated Tale
Dec 02Investors Still Aren't Entirely Convinced By ModivCare Inc.'s (NASDAQ:MODV) Revenues Despite 26% Price Jump
Aug 31
Is ModivCare (NASDAQ:MODV) A Risky Investment?
Jul 11ModivCare Inc. (NASDAQ:MODV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Apr 04ModivCare Inc. (NASDAQ:MODV) Just Reported Earnings, And Analysts Cut Their Target Price
Feb 29ModivCare (NASDAQ:MODV) Seems To Be Using A Lot Of Debt
Feb 22Sentiment Still Eluding ModivCare Inc. (NASDAQ:MODV)
Jan 25Is ModivCare (NASDAQ:MODV) A Risky Investment?
Nov 08Here's Why ModivCare (NASDAQ:MODV) Is Weighed Down By Its Debt Load
Aug 03Is ModivCare (NASDAQ:MODV) A Risky Investment?
Apr 17Is There An Opportunity With ModivCare Inc.'s (NASDAQ:MODV) 49% Undervaluation?
Feb 24Does ModivCare (NASDAQ:MODV) Have A Healthy Balance Sheet?
Oct 12ModivCare: ROIC And Continuing Value Are Narrowing - Rating It A Hold
Sep 02Modivcare names finance boss Heath Sampson as interim CEO
Aug 02ModivCare (NASDAQ:MODV) Has A Somewhat Strained Balance Sheet
Jul 12Are Investors Undervaluing ModivCare Inc. (NASDAQ:MODV) By 37%?
May 10ModivCare (NASDAQ:MODV) Takes On Some Risk With Its Use Of Debt
Mar 04Shareholder Returns
| MODV | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -37.5% | -4.1% | -2.4% |
| 1Y | -74.6% | -10.2% | 23.3% |
Return vs Industry: MODV underperformed the US Healthcare industry which returned -11.4% over the past year.
Return vs Market: MODV underperformed the US Market which returned 22.1% over the past year.
Price Volatility
| MODV volatility | |
|---|---|
| MODV Average Weekly Movement | 13.1% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MODV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MODV's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 21,200 | L. Sampson | www.modivcare.com |
ModivCare Inc., a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other. The company offers risk underwriting, contact center management, network credentialing, claims management, and non-emergency medical transport management services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services.
ModivCare Inc. Fundamentals Summary
| MODV fundamental statistics | |
|---|---|
| Market cap | US$155.55m |
| Earnings (TTM) | -US$183.04m |
| Revenue (TTM) | US$2.79b |
0.1x
P/S Ratio-0.9x
P/E RatioIs MODV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MODV income statement (TTM) | |
|---|---|
| Revenue | US$2.79b |
| Cost of Revenue | US$2.36b |
| Gross Profit | US$432.54m |
| Other Expenses | US$615.58m |
| Earnings | -US$183.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -12.81 |
| Gross Margin | 15.52% |
| Net Profit Margin | -6.57% |
| Debt/Equity Ratio | -7,174.5% |
How did MODV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 08:23 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ModivCare Inc. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| James Kumpel | BB&T Capital Markets |
| Robert Labick | CJS Securities, Inc. |